☆ 4.7 Article

Metformin Therapy Effects on the Expression of Sodium-Glucose Cotransporter 2, Leptin, and SIRT6 Levels in Pericoronary Fat Excised from Pre-Diabetic Patients with Acute Myocardial Infarction

BIOMEDICINES (2021)

Related references

Note: Only part of the references are listed.

Article Endocrinology & Metabolism

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021

Summary: The American Diabetes Association's Standards of Medical Care in Diabetes provides clinical practice recommendations, treatment goals, guidelines, and tools for evaluating care quality. It is updated annually by a multidisciplinary expert committee, and readers are invited to comment on the standards at professional.diabetes.org/SOC.

DIABETES CARE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Pre-Menopausal Breast Fat Density Might Predict MACE During 10 Years of Follow-Up The BRECARD Study

Celestino Sardu et al.

Summary: This study found that pre-menopausal women with higher levels of adipose tissue in breast gland (lowest breast density, category A) had higher rates of MACES. Further clinical trials are needed to translate these results into clinical practice.

JACC-CARDIOVASCULAR IMAGING (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Atherosclerotic Plaque Fissuration and Clinical Outcomes in Pre-Diabetics vs. Normoglycemics Patients Affected by Asymptomatic Significant Carotid Artery Stenosis at 2 Years of Follow-Up: Role of microRNAs Modulation: The ATIMIR Study

Celestino Sardu et al.

Summary: Atherosclerotic plaque instability and rupture in patients with asymptomatic carotid artery stenosis is a leading cause of major adverse cardiac events (MACE). Alterations in glucose homeostasis and insulin resistance can lead to inflammation of atherosclerotic plaque, favoring its conversion to unstable phenotype with rupture and MACE, especially in pre-diabetics. Metformin therapy can reduce MACE in ACAS patients with pre-diabetes by reducing metabolic distress and inflammatory burden. MiRNAs could be used as molecular biomarkers of atherosclerosis progression, plaque rupture, and prognosis in different patient groups.

BIOMEDICINES (2021)

Add to Collection

Article Cell Biology

MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients

Nunzia D'Onofrio et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study

Ferdinando Carlo Sasso et al.

CARDIOVASCULAR DIABETOLOGY (2019)

Add to Collection

Article Endocrinology & Metabolism

Effects of Metformin Therapy on Coronary Endothelial Dysfunction in Patients With Prediabetes With Stable Angina and Nonobstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study

Celestino Sardu et al.

DIABETES CARE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Abdominal Fat SIRT6 Expression and Its Relationship with Inflammatory and Metabolic Pathways in Pre-Diabetic Overweight Patients

Nunzia D'Onofrio et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin

Celestino Sardu et al.

CARDIOVASCULAR DIABETOLOGY (2019)

Add to Collection

Article Endocrinology & Metabolism

Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial

Jordi Salas-Salvado et al.

DIABETES CARE (2019)

Add to Collection

Article Pharmacology & Pharmacy

Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats

Hiroto Oshima et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart

Ven G. Lim et al.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)

Add to Collection

Article Endocrinology & Metabolism

Metformin: Mechanisms in Human Obesity and Weight Loss

Armen Yerevanian et al.

CURRENT OBESITY REPORTS (2019)

Add to Collection

Article Endocrinology & Metabolism

SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management

Michael J. B. van Baar et al.

DIABETES CARE (2018)

Add to Collection

Article Endocrinology & Metabolism

Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes

W. Timothy Garvey et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2018)

Add to Collection

Article Physiology

Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics Patients

Celestino Sardu et al.

FRONTIERS IN PHYSIOLOGY (2018)

Add to Collection

Review Nutrition & Dietetics

Pericoronary Adipose Tissue: A Novel Therapeutic Target in Obesity-Related Coronary Atherosclerosis

Tomasz Mazurek et al.

JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2015)

Add to Collection

© Peeref 2019-2024. All rights reserved.